Compare ENGN & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ENGN | NAUT |
|---|---|---|
| Founded | 1999 | 2016 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Laboratory Analytical Instruments |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 379.3M | 252.6M |
| IPO Year | N/A | N/A |
| Metric | ENGN | NAUT |
|---|---|---|
| Price | $8.99 | $1.92 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $22.71 | N/A |
| AVG Volume (30 Days) | ★ 259.1K | 241.6K |
| Earning Date | 12-22-2025 | 10-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.65 | $0.62 |
| 52 Week High | $11.14 | $2.54 |
| Indicator | ENGN | NAUT |
|---|---|---|
| Relative Strength Index (RSI) | 57.72 | 50.31 |
| Support Level | $7.57 | $1.91 |
| Resistance Level | $9.81 | $2.05 |
| Average True Range (ATR) | 0.72 | 0.13 |
| MACD | 0.06 | -0.02 |
| Stochastic Oscillator | 57.71 | 42.03 |
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.